drugset / Trial / NCT06978049

Use of Lactic Acid Gel for Intravaginal Use, 7 Applicators x 5ml, Bayer to Reduce Post-episiotomy Discomfort

NCT06978049

RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective controlled study evaluates the efficacy of topical lactic acid gel in enhancing episiotomy wound healing and improving postpartum sexual quality of life.

Timeline

Start
2023-01-31
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified 5 ml Topical

Indications

No indication recorded.